|
BCG Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: BCG Live, TICE®, TheraCys®
Birmingham, Alabama1 trial
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
University of Alabama at Birmingham
Phase 1
Bakersfield, California1 trial
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Michael G Oefelein Clinical Trials ( Site 0138)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.